ATNM ▲ +3.0% - Actinium Pharmaceuticals, Inc.
$ATNM ATNM ATNM - Actinium Pharmaceuticals Unveils ATNM?400 Data at EANM 2026 with a First?In?Human HER3?Targeted Radiotherapy Approach Beyond PSMA in Prostate Cancer
20-OCT-2026 08:04 AM ET
Share this post
More filings for $ATNM
ATNM ▲ +0.9% - Actinium Pharmaceuticals, Inc.Oct 19, 2026ATNM ▲ +4.8% - Actinium Pharmaceuticals, Inc.Oct 16, 2026ATNM ▲ +1.0% - Actinium Pharmaceuticals, Inc.Oct 16, 2026ATNM ▲ +1.0% - Actinium Pharmaceuticals, Inc.Oct 16, 2026ATNM ▲ +4.2% - Actinium Pharmaceuticals, Inc.Oct 15, 2026ATNM ▲ +2.1% - Actinium Pharmaceuticals, Inc.Oct 15, 2026
View full $ATNM filing history →💬 Comments
Loading comments…
Leave a comment